2025-01-1920231359-734510.1039/d3cc02929h2-s2.0-85168579166https://doi.org/10.1039/d3cc02929hhttps://hdl.handle.net/20.500.14288/26581Fluorescent, CdSe/CdS core/crown heterostructured nanoplatelets (NPLs) were transferred to the water via a simple, single-step ligand exchange using 2-mercaptopropionic acid in a simple extraction process. These stable, aqueous NPLs were loaded with a modal drug, 5-aminolevulinic acid (ALA). ALA-loaded NPLs emerged as a new class of theranostic nanoparticles for image-guided enhanced photodynamic therapy of both androgen-dependent and -independent human prostate cancer cells.ChemistryAqueous colloidal nanoplatelets for imaging and improved ALA-based photodynamic therapy of prostate cancer cellsJournal Article1364-548X1044599400001Q251016